Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients

Bibliographic Details
Main Author:	Hyde, S
Format:	Conference item
Published:	2013

Similar Items

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016)

A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2015)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
by: McLachlan, G, et al.
Published: (2011)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
by: Pringle, I, et al.
Published: (2009)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
by: Alton, EWFW, et al.
Published: (2015)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
by: Davies, G, et al.
Published: (2011)

Emerging gene therapies for cystic fibrosis
by: Miah, K, et al.
Published: (2019)

A poly-functional gene delivery system for cystic fibrosis
by: Montier, T, et al.
Published: (2017)

Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6.
by: Siegel, D, et al.
Published: (1992)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis.
by: Gonem, S, et al.
Published: (2014)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis
by: Gonem, S, et al.
Published: (2014)

Differential thermostability and response to cystic fibrosis transmembrane conductance regulator (CFTR) potentiators of human and mouse F508del-CFTR
by: Bose, S, et al.
Published: (2019)

Innate immunity in cystic fibrosis lung disease.
by: Hartl, D, et al.
Published: (2012)

Gene transfer vector development to treat lung disease: The use of a dual-function Lentiviral vector containing ENaC RNAi and the CFTR gene to treat Cystic Fibrosis lung disaease
by: Harding-Smith, R
Published: (2014)

Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017)

Chitinase activation in patients with fungus-associated cystic fibrosis lung disease
by: Hector, Andreas, et al.
Published: (2017)

Gene therapy for cystic fibrosis: from basic research to clinical impact
by: Hyde, S
Published: (2013)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
by: Sergijenko, A, et al.
Published: (2020)

Bacteriocin-mediated competition in cystic fibrosis lung infections.
by: Ghoul, M, et al.
Published: (2015)

Polymorphonuclear leukocytes restrict growth of pseudomonas aeruginosa in the lungs of cystic fibrosis patients
by: Moser, Claus, et al.
Published: (2015)

Exploring the mechanisms of macrolides in cystic fibrosis.
by: Equi, A, et al.
Published: (2006)

Colloid and crystal formation in parotid saliva of cystic fibrosis patients and non-cystic fibrosis subjects. II. Electron microscopy and electrophoresis.
by: Allars, H, et al.
Published: (1976)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
by: Alton, E, et al.
Published: (2012)

Cystic Fibrosis in Malaysian Children
by: Norzila, M.Z., et al.
Published: (2005)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
by: Pringle, I, et al.
Published: (2008)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
by: Pringle, I, et al.
Published: (2012)

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
by: Hyde, S, et al.
Published: (1993)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
by: Pringle, I, et al.
Published: (2012)

Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapy
by: Mottais, A, et al.
Published: (2017)

Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
by: Hansen, Christine Rønne, et al.
Published: (2014)

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
by: Griesenbach, U, et al.
Published: (2016)

Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.
by: Eisen, S, et al.
Published: (2004)

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
by: Hyde, S, et al.
Published: (2000)

Microbial interactions in the cystic fibrosis airway
by: Granchelli, AM, et al.
Published: (2018)

Hot topics and current controversies in non-cystic fibrosis bronchiectasis
by: Severiche-Bueno, Diego, et al.
Published: (2020)

A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
by: Gill, DR, et al.
Published: (1997)

Lentiviral delivery of CRISPR Cas9 prime editing system for cystic fibrosis
by: Satyapertiwi, D
Published: (2024)